2024
Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial
Zelenev A, Huedo-Medina T, Shrestha R, Mistler C, Altice F, Sibilio B, Copenhaver M. Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial. PLOS ONE 2024, 19: e0312165. PMID: 39509356, PMCID: PMC11542883, DOI: 10.1371/journal.pone.0312165.Peer-Reviewed Original ResearchConceptsHolistic Health Recovery ProgramEvidence-based interventionsHolistic healthHIV treatmentRisk behaviorsReduce HIV risk behaviorsDifference-in-differencesEnd-of-interventionControlled non-inferiority trialHIV Epidemic goalsDrug treatment settingsAttainment of viral suppressionNon-inferiority trialRecovery programViral suppressionHigh ART adherenceHIV risk behaviorsNon-inferiorityHHRP+ART adherenceBehavioral interventionsReal-world settingsNon-parametric bootstrappingCondom useOpioid-dependent peopleTransactional sex and its associated factors among gay, bisexual and other men who have sex with men in Nepal
Sujan M, Paudel K, Gautam K, Khati A, Wickersham J, Dhakal M, Ha T, Shrestha R. Transactional sex and its associated factors among gay, bisexual and other men who have sex with men in Nepal. Sexual Health 2024, 21 PMID: 39388431, DOI: 10.1071/sh24178.Peer-Reviewed Original ResearchConceptsTransactional sexPrevalence of transactional sexFactors associated with transactional sexExchange of sexReduce transactional sexPolice detentionMental health challengesEconomic vulnerabilityTransgender womenFinancial dependenceGBMSMCondomless sexSubstance useAssociated with adverse health outcomesNepalParticipants' sociodemographic characteristics,Cross-sectional surveyMultivariate logistic regression analysisAdverse health outcomesAge of participantsHealth outcomesSexually transmitted infectionsHigh-risk groupSociodemographic characteristicsLogistic regression analysis
2023
Assessing Barriers and Utilization of Sexual and Reproductive Health Services among Female Migrant Workers in Vietnam
Ha T, Givens D, Shi H, Nguyen T, Nguyen N, Shrestha R, Frank L, Schensul S. Assessing Barriers and Utilization of Sexual and Reproductive Health Services among Female Migrant Workers in Vietnam. International Journal Of Environmental Research And Public Health 2023, 20: 6368. PMID: 37510599, PMCID: PMC10379987, DOI: 10.3390/ijerph20146368.Peer-Reviewed Original ResearchConceptsWomen migrant workersFemale migrant workersMigrant workersSRH servicesReproductive health servicesMigrant women workersHealth servicesWomen workersSRH service utilizationIndustrial zoneLast sexual encounterMultivariable logistic regression analysisSexual encountersUtilization of SexualLogistic regression analysisSimilar contextsTimes higher oddsExplores factorsWorkersUrban settingsCross-sectional surveyVietnamMiddle-income countriesStudy findingsHigher incomePerceived stigma related to TB preventive therapy
Palacios C, Hough M, Shrestha R, Moll A, Kompala T, Andrews L, Shenoi S. Perceived stigma related to TB preventive therapy. The International Journal Of Tuberculosis And Lung Disease 2023, 27: 209-214. PMID: 36855038, DOI: 10.5588/ijtld.22.0570.Peer-Reviewed Original ResearchConceptsTB preventative therapyTB preventive therapyAnonymous cross-sectional surveyBurden of TBCommunity-dwelling adultsRural South African communityCross-sectional surveyPreventive therapyMean agePreventative therapyEndemic settingsPatient's familyKruskal-Wallis testStigma scoresRural South AfricaPoisson regressionNovel interventionsSouth African communityTherapyLess stigmaDescriptive statisticsFamily membersStigmaTBTwo-factor solutionClinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed Methods Evaluation of Usability and Acceptability
Shrestha R, Altice F, Khati A, Azwa I, Gautam K, Gupta S, Sullivan P, Ni Z, Kamarulzaman A, Phiphatkunarnon P, Wickersham J. Clinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed Methods Evaluation of Usability and Acceptability. JMIR MHealth And UHealth 2023, 11: e44468. PMID: 36795465, PMCID: PMC9982718, DOI: 10.2196/44468.Peer-Reviewed Original ResearchConceptsHIV prevention servicesINTERNATIONAL REGISTERED REPORT IDENTIFIERPrevention servicesMean ageHIV preventionPre-exposure prophylaxisHIV prevention outcomesHIV self-testing (HIVST) kitsParticipants' mean ageSelf-testing kitsHealth care settingsMobile health platformMalaysian MSMMixed-methods evaluationHIV testingCare settingsLocal clinicSystem Usability ScalePrevention outcomesDays of testingMSMSmartphone appPrEPHIVMean score
2022
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
Haeuser E, Serfes A, Cork M, Yang M, Abbastabar H, Abhilash E, Adabi M, Adebayo O, Adekanmbi V, Adeyinka D, Afzal S, Ahinkorah B, Ahmadi K, Ahmed M, Akalu Y, Akinyemi R, Akunna C, Alahdab F, Alanezi F, Alanzi T, Alene K, Alhassan R, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw E, Amini S, Amugsi D, Ancuceanu R, Anvari D, Appiah S, Arabloo J, Aremu O, Asemahagn M, Jafarabadi M, Awedew A, Quintanilla B, Ayanore M, Aynalem Y, Azari S, Azene Z, Darshan B, Babalola T, Baig A, Banach M, Bärnighausen T, Bell A, Bhagavathula A, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew Z, Bohlouli S, Bolarinwa O, Boloor A, Bozicevic I, Butt Z, Cárdenas R, Carvalho F, Charan J, Chattu V, Chowdhury M, Chu D, Cowden R, Dahlawi S, Damiani G, Darteh E, Darwesh A, das Neves J, Weaver N, De Leo D, De Neve J, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary S, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu I, Ezzikouri S, Farzadfar F, Fattahi N, Fauk N, Fernandes E, Filip I, Fischer F, Foigt N, Foroutan M, Fukumoto T, Gad M, Gaidhane A, Gebregiorgis B, Gebremedhin K, Getacher L, Ghadiri K, Ghashghaee A, Golechha M, Gubari M, Gugnani H, Guimarães R, Haider M, Haj-Mirzaian A, Hamidi S, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, Ho H, Holla R, Hosseini M, Hosseinzadeh M, Hwang B, Ibitoye S, Ilesanmi O, Ilic I, Ilic M, Islam R, Iwu C, Jakovljevic M, Jha R, Ji J, Johnson K, Joseph N, Joshua V, Joukar F, Jozwiak J, Kalankesh L, Kalhor R, Kamyari N, Kanchan T, Matin B, Karimi S, Kayode G, Karyani A, Keramati M, Khan E, Khan G, Khan M, Khatab K, Khubchandani J, Kim Y, Kisa A, Kisa S, Kopec J, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Defo B, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kusuma D, La Vecchia C, Lal D, Landires I, Larson H, Lasrado S, Lee P, Li S, Liu X, Maleki A, Malik P, Mansournia M, Martins-Melo F, Mendoza W, Menezes R, Mengesha E, Meretoja T, Mestrovic T, Mirica A, Moazen B, Mohamad O, Mohammad Y, Mohammadian-Hafshejani A, Mohammadpourhodki R, Mohammed S, Mohammed S, Mokdad A, Moradi M, Moraga P, Mubarik S, Mulu G, Mwanri L, Nagarajan A, Naimzada M, Naveed M, Nazari J, Ndejjo R, Negoi I, Ngalesoni F, Nguefack-Tsague G, Ngunjiri J, Nguyen C, Nguyen H, Nnaji C, Noubiap J, Nuñez-Samudio V, Nwatah V, Oancea B, Odukoya O, Olagunju A, Olakunde B, Olusanya B, Olusanya J, Bali A, Onwujekwe O, Orisakwe O, Otstavnov N, Otstavnov S, Owolabi M, Mahesh P, Padubidri J, Pana A, Pandey A, Pandi-Perumal S, Kan F, Patton G, Pawar S, Peprah E, Postma M, Preotescu L, Syed Z, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi-Movaghar V, Rahmani A, Ramezanzadeh K, Rana J, Ranabhat C, Rao S, Rawaf D, Rawaf S, Rawassizadeh R, Regassa L, Rezaei N, Rezapour A, Riaz M, Ribeiro A, Ross J, Rubagotti E, Rumisha S, Rwegerera G, Moghaddam S, Sagar R, Sahiledengle B, Sahu M, Salem M, Kafil H, Samy A, Sartorius B, Sathian B, Seidu A, Shaheen A, Shaikh M, Shamsizadeh M, Shiferaw W, Shin J, Shrestha R, Singh J, Skryabin V, Skryabina A, Soltani S, Sufiyan M, Tabuchi T, Tadesse E, Taveira N, Tesfay F, Thapar R, Tovani-Palone M, Tsegaye G, Umeokonkwo C, Unnikrishnan B, Villafañe J, Violante F, Vo B, Vu G, Wado Y, Waheed Y, Wamai R, Wang Y, Ward P, Wickramasinghe N, Wilson K, Yaya S, Yip P, Yonemoto N, Yu C, Zastrozhin M, Zhang Y, Zhang Z, Hay S, Dwyer-Lindgren L. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018. BMC Medicine 2022, 20: 488. PMID: 36529768, PMCID: PMC9760541, DOI: 10.1186/s12916-022-02639-z.Peer-Reviewed Original ResearchConceptsHIV prevalenceAge groupsBackgroundHuman immunodeficiency virusJoint United Nations ProgrammeImmune deficiency syndromeHIV prevalence estimatesAdults ages 15HIV/AIDSClinic attendeesUnited Nations ProgrammeImmunodeficiency virusSentinel surveillanceDisease burdenDeficiency syndromePrevalence increasesSeroprevalence surveyPrevalence trendsLow prevalencePrevalence estimatesTreatment interventionsPrevalence differencesTargeted interventionsPrevalenceTreatment effortsAge 15Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
Collaborators G, Bryazka D, Reitsma M, Griswold M, Abate K, Abbafati C, Abbasi-Kangevari M, Abbasi-Kangevari Z, Abdoli A, Abdollahi M, Abdullah A, Abhilash E, Abu-Gharbieh E, Acuna J, Addolorato G, Adebayo O, Adekanmbi V, Adhikari K, Adhikari S, Adnani Q, Afzal S, Agegnehu W, Aggarwal M, Ahinkorah B, Ahmad A, Ahmad S, Ahmad T, Ahmadi A, Ahmadi S, Ahmed H, Rashid T, Akunna C, Al Hamad H, Alam Z, Alem D, Alene K, Alimohamadi Y, Alizadeh A, Allel K, Alonso J, Alvand S, Alvis-Guzman N, Amare F, Ameyaw E, Amiri S, Ancuceanu R, Anderson J, Andrei C, Andrei T, Arabloo J, Arshad M, Artamonov A, Aryan Z, Asaad M, Asemahagn M, Astell-Burt T, Athari S, Atnafu D, Atorkey, Atreya A, Ausloos F, Ausloos M, Ayano G, Ayanore M, Ayinde O, Ayuso-Mateos J, Azadnajafabad S, Azanaw M, Azangou-Khyavy M, Jafari A, Azzam A, Badiye A, Bagheri N, Bagherieh S, Bairwa M, Bakkannavar S, Bakshi R, Balchut/Bilchut A, Bärnighausen T, Barra F, Barrow A, Baskaran P, Belo L, Bennett D, Benseñor I, Bhagavathula A, Bhala N, Bhalla A, Bhardwaj N, Bhardwaj P, Bhaskar S, Bhattacharyya K, Bhojaraja V, Bintoro B, Blokhina E, Bodicha B, Boloor A, Bosetti C, Braithwaite D, Brenner H, Briko N, Brunoni A, Butt Z, Cao C, Cao Y, Cárdenas R, Carvalho A, Carvalho M, Castaldelli-Maia J, Castelpietra G, Castro-de-Araujo L, Cattaruzza M, Chakraborty P, Charan J, Chattu V, Chaurasia A, Cherbuin N, Chu D, Chudal N, Chung S, Churko C, Ciobanu L, Cirillo M, Claro R, Costanzo S, Cowden R, Criqui M, Cruz-Martins N, Culbreth G, Dachew B, Dadras O, Dai X, Damiani G, Dandona L, Dandona R, Daniel B, Danielewicz A, Gela J, Davletov K, de Araujo J, de Sá-Junior A, Debela S, Dehghan A, Demetriades A, Molla M, Desai R, Desta A, da Silva D, Diaz D, Digesa L, Diress M, Dodangeh M, Dongarwar D, Dorostkar F, Dsouza H, Duko B, Duncan B, Edvardsson K, Ekholuenetale M, Elgar F, Elhadi M, Elmonem M, Endries A, Eskandarieh S, Etemadimanesh A, Fagbamigbe A, Fakhradiyev I, Farahmand F, Farinha C, Faro A, Farzadfar F, Fatehizadeh A, Fauk N, Feigin V, Feldman R, Feng X, Fentaw Z, Ferrero S, Desideri L, Filip I, Fischer F, Francis J, Franklin R, Gaal P, Gad M, Gallus S, Galvano F, Ganesan B, Garg T, Gebrehiwot M, Gebremeskel T, Gebremichael M, Gemechu T, Getacher L, Getachew M, Obsa A, Getie A, Ghaderi A, Ghafourifard M, Ghajar A, Ghamari S, Ghandour L, Nour M, Ghashghaee A, Ghozy S, Glozah F, Glushkova E, Godos J, Goel A, Goharinezhad S, Golechha M, Goleij P, Golitaleb M, Greaves F, Grivna M, Grosso G, Gudayu T, Gupta B, Gupta R, Gupta S, Gupta V, Gupta V, Hafezi-Nejad N, Haj-Mirzaian A, Hall B, Halwani R, Handiso T, Hankey G, Hariri S, Haro J, Hasaballah A, Hassanian-Moghaddam H, Hay S, Hayat K, Heidari G, Heidari M, Hendrie D, Herteliu C, Heyi D, Hezam K, Hlongwa M, Holla R, Hossain M, Hossain S, Hosseini S, hosseinzadeh M, Hostiuc M, Hostiuc S, Hu G, Huang J, Hussain S, Ibitoye S, Ilic I, Ilic M, Immurana M, Irham L, Islam M, Islam R, Islam M, Iso H, Itumalla R, Iwagami M, Jabbarinejad R, Jacob L, Jakovljevic M, Jamalpoor Z, Jamshidi E, Jayapal S, Jayarajah U, Jayawardena R, Jebai R, Jeddi S, Jema A, Jha R, Jindal H, Jonas J, Joo T, Joseph N, Joukar F, Jozwiak J, Jürisson M, Kabir A, Kabthymer R, Kamble B, Kandel H, Kanno G, Kapoor N, Karaye I, Karimi S, Kassa B, Kaur R, Kayode G, Keykhaei M, Khajuria H, Khalilov R, Khan I, Khan M, Kim H, Kim J, Kim M, Kimokoti R, Kivimäki M, Klymchuk V, Knudsen A, Kolahi A, Korshunov V, Koyanagi A, Krishan K, Krishnamoorthy Y, Kumar G, Kumar N, Kumar N, Lacey B, Lallukka T, Lasrado S, Lau J, Lee S, Lee W, Lee Y, Lim L, Lim S, Lobo S, Lopukhov P, Lorkowski S, Lozano R, Lucchetti G, Madadizadeh F, Madureira-Carvalho Á, Mahjoub S, Mahmoodpoor A, Mahumud R, Makki A, Malekpour M, Manjunatha N, Mansouri B, Mansournia M, Martinez-Raga J, Martinez-Villa F, Matzopoulos R, Maulik P, Mayeli M, McGrath J, Meena J, Nasab E, Menezes R, Mensink G, Mentis A, Meretoja A, Merga B, Mestrovic T, Jonasson J, Miazgowski B, de Sá A, Miller T, Mini G, Mirica A, Mirijello A, Mirmoeeni S, Mirrakhimov E, Misra S, Moazen B, Mobarakabadi M, Moccia M, Mohammad Y, Mohammadi E, Mohammadian-Hafshejani A, Mohammed T, Moka N, Mokdad A, Momtazmanesh S, Moradi Y, Mostafavi E, Mubarik S, Mullany E, Mulugeta B, Murillo-Zamora E, Murray C, Mwita J, Naghavi M, Naimzada M, Nangia V, Nayak B, Negoi I, Negoi R, Nejadghaderi S, Nepal S, Neupane S, Kandel S, Nigatu Y, Nowroozi A, Nuruzzaman K, Nzoputam C, Obamiro K, Ogbo F, Oguntade A, Okati-Aliabad H, Olakunde B, Oliveira G, Bali A, Omer E, Ortega-Altamirano D, Otoiu A, Otstavnov S, Oumer B, Mahesh P, Padron-Monedero A, Palladino R, Pana A, Panda-Jonas S, Pandey A, Pandey A, Pardhan S, Parekh T, Park E, Parry C, Kan F, Patel J, Pati S, Patton G, Paudel U, Pawar S, Peden A, Petcu I, Phillips M, Pinheiro M, Plotnikov E, Pradhan P, Prashant A, Quan J, Radfar A, Rafiei A, Raghav P, Rahimi-Movaghar V, Rahman A, Rahman M, Rahman M, Rahmani A, Rahmani S, Ranabhat C, Ranasinghe P, Rao C, Rasali D, Rashidi M, Ratan Z, Rawaf D, Rawaf S, Rawal L, Renzaho A, Rezaei N, Rezaei S, Rezaeian M, Riahi S, Romero-Rodríguez E, Roth G, Rwegerera G, Saddik B, Sadeghi E, Sadeghian R, Saeed U, Saeedi F, Sagar R, Sahebkar A, Sahoo H, Sahraian M, Saif-Ur-Rahman K, Salahi S, Salimzadeh H, Samy A, Sanmarchi F, Santric-Milicevic M, Sarikhani Y, Sathian B, Saya G, Sayyah M, Schmidt M, Schutte A, Schwarzinger M, Schwebel D, Seidu A, Kumar N, SeyedAlinaghi S, Seylani A, Sha F, Shahin S, Shahraki-Sanavi F, Shahrokhi S, Shaikh M, Shaker E, Shakhmardanov M, Shams-Beyranvand M, Sheikhbahaei S, Sheikhi R, Shetty A, Shetty J, Shiferaw D, Shigematsu M, Shiri R, Shirkoohi R, Shivakumar K, Shivarov V, Shobeiri P, Shrestha R, Sidemo N, Sigfusdottir I, Silva D, da Silva N, Singh J, Singh S, Skryabin V, Skryabina A, Sleet D, Solmi M, SOLOMON Y, Song S, Song Y, Sorensen R, Soshnikov S, Soyiri I, Stein D, Subba S, Szócska M, Tabarés-Seisdedos R, Tabuchi T, Taheri M, Tan K, Tareke M, Tarkang E, Temesgen G, Temesgen W, Temsah M, Thankappan K, Thapar R, Thomas N, Tiruneh C, Todorovic J, Torrado M, Touvier M, Tovani-Palone M, Tran M, Trias-Llimós S, Tripathy J, Vakilian A, Valizadeh R, Varmaghani M, Varthya S, Vasankari T, Vos T, Wagaye B, Waheed Y, Walde M, Wang C, Wang Y, Wang Y, Westerman R, Wickramasinghe N, Wubetu A, Xu S, Yamagishi K, Yang L, Yesera G, Yigit A, Yiğit V, Yimaw A, Yon D, Yonemoto N, Yu C, Zadey S, Zahir M, Zare I, Zastrozhin M, Zastrozhina A, Zhang Z, Zhong C, Zmaili M, Zuniga Y, Gakidou E. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet 2022, 400: 185-235. PMID: 35843246, PMCID: PMC9289789, DOI: 10.1016/s0140-6736(22)00847-9.Peer-Reviewed Original ResearchConceptsTheoretical minimum risk exposure levelStandard drinksAlcohol consumptionGlobal burdenHealth outcomesDisease ratesModerate alcohol consumptionRelative risk curveHealth risksPopulation-level riskAge groupsRisk curvesOverall riskRisk exposure levelAlcohol useHarmful amountsMelinda Gates FoundationHealth lossYoung individualsExposure levelsAgeRiskSexDrinksDaysRace, Trust, and COVID-19 Vaccine Hesitancy in People with Opioid Use Disorder
Sullivan MC, Mistler C, Copenhaver MM, Wickersham JA, Ni Z, Kim RS, Shrestha R. Race, Trust, and COVID-19 Vaccine Hesitancy in People with Opioid Use Disorder. Health Psychology 2022, 41: 115-120. PMID: 34855415, PMCID: PMC9754617, DOI: 10.1037/hea0001120.Peer-Reviewed Original ResearchConceptsOpioid use disorderMethadone maintenance programEffective vaccineVaccine hesitancyUse disordersCOVID-19 vaccine hesitancyInjection drug useEffective COVID-19 vaccineCoronavirus disease 2019COVID-19 vaccineCOVID-19Sexual risk behaviorsSocial risk factorsVaccine uptakeRisk factorsVaccination willingnessRisk groupsDisease 2019Psychosocial factorsDrug useProactive outreachPhysician ScaleRisk behaviorsHealth disparitiesVaccine
2021
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
Collaborators G, Kendrick P, Reitsma M, Abbasi-Kangevari M, Abdoli A, Abdollahi M, Abedi A, Abhilash E, Aboyans V, Adebayo O, Advani S, Ahinkorah B, Ahmad S, Ahmadi K, Ahmed H, Aji B, Akalu Y, Akunna C, Alahdab F, Al-Aly Z, Alanezi F, Alanzi T, Alhabib K, Ali T, Alif M, Alipour V, Aljunid S, Alomari M, Amin T, Amini S, Amu H, Ancuceanu R, Anderson J, Andrei C, Andrei T, Ansari-Moghaddam A, Antony B, Anvari D, Arabloo J, Arian N, Arora M, Artanti K, Asmare W, Atnafu D, Ausloos M, Awan A, Ayano G, Aynalem G, Azari S, Darshan B, Badiye A, Baig A, Banach M, Banerjee S, Barker-Collo S, Bärnighausen T, Barqawi H, Basu S, Bayati M, Bazargan-Hejazi S, Bekuma T, Bennett D, Bensenor I, Benzian H, Benziger C, Berman A, Bhagavathula A, Bhala N, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bibi S, Bijani A, Biondi A, Braithwaite D, Brenner H, Brunoni A, Burkart K, Nagaraja S, Butt Z, dos Santos F, Car J, Carreras G, Castaldelli-Maia J, Cattaruzza M, Chang J, Chaturvedi P, Chen S, Chido-Amajuoyi O, Chu D, Chung S, Ciobanu L, Costa V, Couto R, Dagnew B, Dai X, Damasceno A, Damiani G, Dandona L, Dandona R, Daneshpajouhnejad P, Gela J, Molla M, Desta A, Dharmaratne S, Dhimal M, Eagan A, Kalan M, Edvardsson K, Effiong A, Tantawi M, Elbarazi I, Esmaeilnejad S, Fadhil I, Faraon E, Farwati M, Farzadfar F, Fazlzadeh M, Feigin V, Feldman R, Filip I, Filippidis F, Fischer F, Flor L, Foigt N, Folayan M, Foroutan M, Gad M, Gallus S, Geberemariyam B, Gebregiorgis B, Getacher L, Obsa A, Ghafourifard M, Gheshlagh R, Ghashghaee A, Ghith N, Gil G, Gill P, Ginawi I, Goharinezhad S, Golechha M, Gopalani S, Gorini G, Grivna M, Guha A, Guimarães R, Guo Y, Gupta R, Gupta R, Gupta T, Gupta V, Hafezi-Nejad N, Haider M, Hamadeh R, Hankey G, Hargono A, Hay S, Heidari G, Herteliu C, Hezam K, Hird T, Holla R, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hsiao T, Huang J, Ibeneme C, Ibitoye S, Ilic I, Ilic M, Inbaraj L, Irvani S, Islam J, Islam R, Islam M, Islami F, Iso H, Itumalla R, Jaafari J, Jain V, Jakovljevic M, Jang S, Jayaram S, Jeemon P, Jha R, Jonas J, Jürisson M, Kabir A, Kabir Z, Kalankesh L, Kanchan T, Kandel H, Kapoor N, Karch A, Karimi S, Kebede K, Kelkay B, Kennedy R, Khader Y, Khan E, Khayamzadeh M, Kim G, Kimokoti R, Kivimäki M, Kosen S, Laxminarayana S, Koyanagi A, Krishan K, Kugbey N, Kumar G, Kumar N, Kurmi O, Kusuma D, Lacey B, Landires I, Lasrado S, Lauriola P, Lee D, Lee Y, Leung J, Li S, Lin H, Liu W, Lugo A, Kunjathur S, Majeed A, Maleki A, Malekzadeh R, Malta D, Mamun A, Manjunatha N, Mansouri B, Mansournia M, Martini S, Mathur M, Mathur P, Mazidi M, McKee M, Medina-Solís C, Mehata S, Mendoza W, Menezes R, Miazgowski B, Michalek I, Miller T, Mini G, Mirica A, Mirrakhimov E, Mirzaei H, Misra S, Mohammad Y, Mohammadian-Hafshejani A, Mohammed S, Mokdad A, Molokhia M, Monasta L, Moni M, Moradzadeh R, Morrison S, Mossie T, Mubarik S, Mullany E, Murray C, Nagaraju S, Naghavi M, Naik N, Nalini, Nangia V, Naqvi A, Swamy S, Naveed M, Nazari J, Nduaguba S, Negoi R, Kandel S, Nguyen H, Nigatu Y, Nixon M, Nnaji C, Noubiap J, Nowak C, Nuñez-Samudio V, Ogbo F, Oguntade A, Oh I, Olagunju A, Owolabi M, Mahesh P, Pakshir K, Pana A, Panagiotakos D, Panda-Jonas S, Pandey A, Parekh U, Park E, Park E, Kan F, Pathak M, Pawar S, Pestell R, Pham H, Pinheiro M, Pokhrel K, Pourshams A, Prashant A, Radfar A, Rahimi-Movaghar V, Rahman M, Rahman M, Rahmani A, Ram P, Rana J, Ranabhat C, Rathi P, Rawaf D, Rawaf S, Rawassizadeh R, Renzaho A, Rezapour A, Riaz M, Roever L, Ronfani L, Roshandel G, Roy A, Roy B, Saddik B, Sahebkar A, Salehi S, Salimzadeh H, Samy A, Sanabria J, Santric-Milicevic M, Jose B, Sathian B, Sawhney M, Saya G, Schwendicke F, Seidu A, Kumar N, Sepanlou S, Shafaat O, Shah S, Shaikh M, Shannawaz M, Sharafi K, Sheikh A, Sheikhbahaei S, Shigematsu M, Shiri R, Shishani K, Shivakumar K, Shivalli S, Shrestha R, Siabani S, Sidemo N, Sigfusdottir I, Sigurvinsdottir R, Silva J, Singh A, Singh J, Singh V, Sinha D, Skryabin V, Skryabina A, Soroush A, Soyiri I, Sreeramareddy C, Stein D, Steiropoulos P, Stortecky S, Straif K, Abdulkader R, Sulo G, Sundström J, Tabuchi T, Tadesse E, Tamiru A, Tareke M, Tareque I, Tarigan I, Thakur B, Thankappan K, Thapar R, Tolani M, Tovani-Palone M, Tran B, Tripathy J, Tsegaye G, Tymeson H, Ullah S, Unim B, Updike R, Uthman O, Vacante M, Vardavas C, Venketasubramanian N, Verma M, Vidale S, Vo B, Vu G, Waheed Y, Wang Y, Welding K, Werdecker A, Whisnant J, Wickramasinghe N, Wubishet B, Yamagishi K, Yano Y, Yazdi-Feyzabadi V, Yeshaw Y, Yimmer M, Yonemoto N, Yousefi Z, Yu C, Yunusa I, Yusefzadeh H, Zaman M, Zamani M, Zamanian M, Zastrozhin M, Zastrozhina A, Zhang J, Zhang Z, Zhong C, Zuniga Y, Gakidou E. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Public Health 2021, 6: e482-e499. PMID: 34051920, PMCID: PMC8251505, DOI: 10.1016/s2468-2667(21)00065-7.Peer-Reviewed Original ResearchConceptsGlobal age-standardised prevalenceAge-standardised prevalenceTobacco useSignificant decreaseGlobal burdenRisk Factors Study (GBD) 2019Substantial public health problemDisease Study 2019High prevalence countriesAdverse health outcomesPublic health problemSmokeless tobacco useSmokeless tobacco productsGlobal health communitySmoking tobaccoPrevalence countriesSmoking useHigh prevalenceTobacco usersWHO Framework ConventionHealth outcomesHealth problemsPrevalenceSame time periodTobacco productsThe Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals
Mistler CB, Curley CM, Rosen AO, El-Krab R, Wickersham JA, Copenhaver MM, Khati A, Shrestha R. The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals. Journal Of Community Health 2021, 46: 960-966. PMID: 33770334, PMCID: PMC7996112, DOI: 10.1007/s10900-021-00979-0.Peer-Reviewed Original ResearchConceptsOpioid use disorderHIV prevention servicesSTI testingHIV counselorsPrEP prescriptionPrevention servicesCOVID-19Pre-exposure prophylaxis servicesOpioid use disorder treatmentCOVID-19 pandemicClean injection equipmentOpioid-dependent individualsOpioid-dependent peopleUse disorder treatmentInjection equipmentHIV testingInfection testingBlood testingHIV preventionUse disordersPWIDDisorder treatmentDoctor's appointmentAdverse effectsCase managersWillingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment
Ni Z, Altice FL, Wickersham JA, Copenhaver MM, DiDomizio EE, Nelson LE, Shrestha R. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment. Drug And Alcohol Dependence 2021, 219: 108477. PMID: 33422864, PMCID: PMC7946167, DOI: 10.1016/j.drugalcdep.2020.108477.Peer-Reviewed Original ResearchConceptsOpioid-dependent individualsPre-exposure prophylaxisPrEP useHIV riskHealthcare providersSex-related risk behaviorsMultivariable logistic regression analysisAwareness of PrEPUrban methadone clinicMultiple logistic regressionDisproportionate HIV burdenLogistic regression analysisCross-sectional surveyHIV burdenHIV infectionHIV testingIndependent correlatesMethadone clinicsDrug treatmentRisk behaviorsLogistic regressionPrEPPrevious useHigher likelihoodProphylaxis
2020
Response to the COVID-19 Outbreak in Urban Settings in China
Ni Z, Lebowitz ER, Zou Z, Wang H, Liu H, Shrestha R, Zhang Q, Hu J, Yang S, Xu L, Wu J, Altice FL. Response to the COVID-19 Outbreak in Urban Settings in China. Journal Of Urban Health 2020, 98: 41-52. PMID: 33258088, PMCID: PMC7703725, DOI: 10.1007/s11524-020-00498-8.Peer-Reviewed Original ResearchUsing individual stated-preferences to optimize HIV self-testing service delivery among men who have sex with men (MSM) in Malaysia: results from a conjoint-based analysis
Shrestha R, Alias H, Wong LP, Altice FL, Lim SH. Using individual stated-preferences to optimize HIV self-testing service delivery among men who have sex with men (MSM) in Malaysia: results from a conjoint-based analysis. BMC Public Health 2020, 20: 1777. PMID: 33238941, PMCID: PMC7687720, DOI: 10.1186/s12889-020-09832-w.Peer-Reviewed Original ResearchConceptsClinic-based HIV testingHIV testing uptakeMethodsA cross-sectional online surveyCross-sectional online surveyNational AIDS ProgramAcceptability of HIVSTMalaysian MSMHIV testingTesting uptakeService delivery programsKey populationsHIVSTService delivery modelsAIDS ProgramMSMKit deliveryTelephone hotlineService delivery approachHigh acceptabilityDelivery programsMultiple barriersSafe useMean acceptabilityDelivery approachDelivery modelAssociation between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment
Copenhaver MM, Sanborn V, Shrestha R, Mistler C, Gunstad J. Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment. Journal Of Addictive Diseases 2020, 39: 166-174. PMID: 33047651, PMCID: PMC11395862, DOI: 10.1080/10550887.2020.1831129.Peer-Reviewed Original ResearchConceptsMethadone maintenance therapyDrug treatmentNeurocognitive dysfunctionNeurocognitive impairmentOpioid use disorderPossible clinical utilityAccommodation of patientsNIH ToolboxSubjective cognitive dysfunctionMaintenance therapyObjective cognitive testingSpecific neurocognitive profileTreatment outcomesCognitive dysfunctionClinical utilityUse disordersBrief inventoryObjective test performanceDysfunctionCognitive testingCutoff scoreNeurocognitive profileTest batteryObjective performanceImpairment
2019
Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study
Shrestha R, Altice FL, Sibilio B, Ssenyonjo J, Copenhaver MM. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study. Contemporary Clinical Trials 2019, 82: 77-84. PMID: 31229618, PMCID: PMC6639056, DOI: 10.1016/j.cct.2019.06.012.Peer-Reviewed Original ResearchConceptsBio-behavioral interventionHIV risk reductionOpioid-dependent peopleMethadone maintenance programPrEP adherenceHIV transmission risk reductionFirst prospective trialPre-exposure prophylaxisHIV prevention strategiesOngoing drug useRisk reductionBehavioral skills modelProspective trialSecondary outcomesPrimary outcomeRisk reduction outcomesHIV riskWeek 20Prevention strategiesUnmet needDrug useHybrid type IBio-behavioral approachProcess evaluationAdherenceHIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients
Shrestha R, Altice FL, Copenhaver MM. HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 80: 166-173. PMID: 30383588, PMCID: PMC6331231, DOI: 10.1097/qai.0000000000001891.Peer-Reviewed Original ResearchConceptsOptimal ART adherenceAntiretroviral therapyMethadone-maintained patientsMethadone maintenance treatmentART adherenceMaintenance treatmentHIV treatment outcomesHIV-positive patientsOpioid agonist therapyMultivariable logistic regressionHIV risk behaviorsExplanatory pathwaysAgonist therapySuboptimal adherenceMedication adherenceHIV treatmentTreatment outcomesHIV stigmaPatientsLogistic regressionHIVPrevention initiativesTherapyAdherenceSignificant correlates
2018
HIV Sero-Status Non-disclosure Among HIV-Infected Opioid-Dependent Individuals: The Roles of HIV-Related Stigma, Risk Behavior, and Social Support
Shrestha R, Altice FL, Sibilio B, Copenhaver MM. HIV Sero-Status Non-disclosure Among HIV-Infected Opioid-Dependent Individuals: The Roles of HIV-Related Stigma, Risk Behavior, and Social Support. Journal Of Community Health 2018, 44: 112-120. PMID: 30043195, PMCID: PMC6330145, DOI: 10.1007/s10900-018-0560-7.Peer-Reviewed Original ResearchConceptsOpioid-dependent individualsOpioid-dependent patientsHIV statusFamily/friendsSexual partnersHIV disclosureHIV sero-status disclosureRisk behaviorsHIV sero statusAntiretroviral therapy adherenceHigh-risk HIVRole of HIVMultivariable logistic regressionSubstance abuse treatment settingsHIV risk behaviorsInconsistent condom useMultiple sex partnersSocial supportHigh HIVSero statusHIV transmissionTherapy adherenceIndependent correlatesHIV riskHIV stigmaViral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART)
Shrestha R, Copenhaver MM. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART). Addictive Behaviors 2018, 85: 88-93. PMID: 29879611, PMCID: PMC6337064, DOI: 10.1016/j.addbeh.2018.05.031.Peer-Reviewed Original ResearchConceptsMethadone maintenance therapyMethadone-maintained patientsOngoing injection drug useViral suppressionAntiretroviral therapyInjection drug useHIV risk behaviorsDrug useSelf-reported HIV risk behaviorsImproved virologic outcomesOptimal ART adherenceHigher CD4 countsSustained viral suppressionMultivariable logistic regressionVirologic outcomesCD4 countMaintenance therapyOptimal adherenceART adherenceHIV treatmentIndependent correlatesTreatment challengesRisk populationsPatientsHIVIntegrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study
Shrestha R, Altice FL, Karki P, Copenhaver MM. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study. AIDS And Behavior 2018, 22: 2640-2649. PMID: 29582199, PMCID: PMC6051885, DOI: 10.1007/s10461-018-2099-0.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidBiobehavioral SciencesCondomsFeasibility StudiesFemaleHIV InfectionsHumansMaleMedication AdherenceMethadoneMiddle AgedMotivationOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePilot ProjectsPre-Exposure ProphylaxisProspective StudiesRisk Reduction BehaviorSexual BehaviorSexual PartnersSubstance Abuse, IntravenousConceptsPre-exposure prophylaxis adherenceSelf-reported PrEP adherenceSex-related risk behaviorsHIV risk reduction behaviorsBio-behavioral interventionPre-exposure prophylaxisProspective clinical trialsHigh-risk peopleHIV prevention interventionsHIV risk behaviorsPilot feasibility studyPost-intervention assessmentPrEP adherenceProphylaxis adherencePreliminary efficacyClinical trialsIntervention groupHIV riskPrevention interventionsRisk behaviorsBio-behavioral approachAdherenceInterventionHigh acceptabilityPrEP
2017
Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users
Shrestha R, Karki P, Altice FL, Dubov O, Fraenkel L, Huedo-Medina T, Copenhaver M. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users. AIDS And Behavior 2017, 22: 1228-1238. PMID: 28695388, PMCID: PMC5762432, DOI: 10.1007/s10461-017-1851-1.Peer-Reviewed Original ResearchConceptsPre-exposure prophylaxisSex-related risk behaviorsHigh-risk drug usersAcceptability of PrEPHigh-risk PWUDPrimary HIV preventionHIV prevention approachesDrug treatment settingsKey risk populationsHIV-negative PWUDHigh acceptabilityHIV clinicPrEP acceptabilityHIV testingPrEP uptakeMethadone clinicsHIV preventionRisk populationsSide effectsTreatment settingsDrug usersPrEP attributesRisk behaviorsPrEPUnderserved populations